Form 4: Takeda Pharmaceutical Co Executive Sells Shares
Insider Transaction (Form 4)
Awny Samaan Botros Farajallah, Chief Medical Officer of Takeda Pharmaceutical Co Ltd, sold 14,006 shares of common stock on August 10, 2026 for $17.10 per share.
Summary
- Open-market sale: disposed of 14,006 American Depositary Shares at $17.10 ($239,503) on August 10, 2026; holds 116,177 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $239,503 of stock on the open market.
Insider Transactions
Awny Samaan Botros Farajallah — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Open-market sale | American Depositary Shares | 14,006 | $17 | $239.5K | 116,177 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Open-market sale (14,006 shares) |
Keywords
insider transaction, Form 4, TAK, TAKEDA PHARMACEUTICAL CO LTD, bearish, Awny Samaan Botros Farajallah
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.